Intersect Capital’s Immunogen Inc IMGN Stock Holding History

Intersect Capital’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-164	Closed	-$1K	–	387
2015 Q1	$1K	Hold	164	–	–	﹤0.01%	428
2014 Q4	$1K	Buy	+164	New	+$1.5K	﹤0.01%	438

Other funds holding IMGN

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Intersect Capital's IMGN Position: Q2 2015 in Review

Intersect Capital sold out of Immunogen Inc (IMGN) in Q2 2015, closing a stake of 164 shares — an estimated $1K sold.

Intersect Capital first reported a position in IMGN in Q4 2014 and held it in 2 quarters. The position peaked at $1K in Q1 2015. 140 funds tracked by Wall St. Rank hold IMGN as of Q2 2015.

Intersect Capital reported no remaining Immunogen Inc position as of Q2 2015 after selling out during the quarter.
Intersect Capital sold 164 Immunogen Inc shares in Q2 2015, an estimated $1K.
Intersect Capital first reported a position in Immunogen Inc in Q4 2014 and held it in 2 quarters.
Intersect Capital's Immunogen Inc position peaked at $1K in Q1 2015.
140 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2015.

Based on Intersect Capital's 13F filing for Q2 2015, filed 3 Aug 2015.